Recommendations for bowel obstruction with peritoneal carcinomatosis

Area of Science:

• Oncology
• Gastroenterology
• Clinical Practice Guidelines

Background:

• Peritoneal carcinomatosis frequently causes intestinal obstruction.
• Management of intestinal obstruction in this context presents significant challenges.

Purpose of the Study:

• To establish clinical practice guidelines for managing intestinal obstruction in patients with peritoneal carcinomatosis.
• To define indications and uses for available treatment options.

Main Methods:

• Multidisciplinary expert group development.
• Comprehensive literature review and expert opinion synthesis.
• Clinical and radiological evaluation, including CT scans, to guide treatment decisions.

Main Results:

• Symptomatic management with medications (glucocorticoids, antiemetics, analgesics, antisecretories) is primary when surgery or stenting is not feasible.
• Somatostatin analogues show efficacy for obstruction symptoms but have limitations in first-line use.
• Venting gastrostomy is considered if medical management fails; rehydration is essential.

Conclusions:

• Guidelines emphasize a tailored approach, prioritizing conservative management and symptom control.
• Treatment decisions integrate clinical, radiological, and prognostic factors.
• Further research may clarify optimal use of specific agents like somatostatin analogues.